Johnson, who earned over $300 million when his mobile and web payment company Braintree was acquired by PayPal in 2013, has ...

Take a look around any wellness space today, and you’ll find plenty of lifestyle ... not quite a vitamin pill, but a ‘super supplement’ containing 8 ingredients that cannot be found in sufficient ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Fiber is crucial to health, but many people fall short of their needs. Fiber supplements can help people who don't obtain ...

Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...

How do you know how healthy your gut is? If you have a healthy and varied diet consisting of a wide variety of plants but few unhealthy or ultra-processed foods, there is a good chance your gut ...

Eli Lilly & Co. (LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026. CEO Dave Ricks told Bloomberg News on Monday that data on the drug, orforglipron ...

The Broncos will have plenty to work with, as they have an estimated $48 million salary cap, plenty of draft picks, and wealthy owners who can circumvent the salary cap by using contract bonuses.

Eli Lilly expects its experimental weight loss pill, orforglipron, to receive approval as early as next year, CEO David Ricks told Bloomberg Jan. 13. The company is preparing to release key late ...

Eli Lilly expects its experimental weight loss pill, orforglipron, to be approved as soon as early next year, CEO David Ricks told Bloomberg. Eli Lilly and Novo Nordisk, which dominate the market ...